🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Inertial Sensors for Obstetrical Walking Epidural Tracking

Recruitingn/aAges 18 Years - 40 YearsFemaleHospices Civils de Lyon
NCT06471790 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Freedom of movement and the ability to walk are crucial during the first stage of labor, potentially reducing labor duration, cesarean section risk, epidural analgesia use, and bladder catheterization. While the clinical effects of ambulation during labor remain controversial, there is a consensus on its positive impact on the birthing experience and satisfaction. Epidural analgesia remains the gold standard for pain control during labor, with a utilization rate of 82% in France. Recent advancements in obstetric analgesia have allowed for lower doses of analgesics, often administered via patient-controlled analgesia, which maintains the potential for ambulation during labor. However, only a small number of maternity units in France offer this technique. The main barriers include organizational issues such as unsuitable facilities, lack of wireless telemetry, and potential risks such as

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * pregnancy \>= 38 gestation weeks * no significant medical history (American Society of Anesthesiologists class ASA 1) * receiving low-dose epidural analgesia with ambulation (in accordance with current service protocol) * not opposed to the study Exclusion Criteria: * Refusal to participate in this study * Non-French-speaking patient * History of osteoarticular pathology likely to change gate (severe scoliosis, spinal surgery, congenital hip deformity, pelvic fracture, ligament or knee joint pathology) * adults under legal protection * multiple pregnancy * need for continuous intravenous infusion with infusion stand during ambulation
💊

What it tests

  • Not listed
📍

Where

1 site
Hôpital de la Croix Rousse
Lyon, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy